If you could vote on Brexit now which option would you choose?
   

Johnson & Johnson runs into vaccine supply issues in Europe, threatening second-quarter delivery pledge: Reuters


Johnson & Johnson execs have assured investors and officials that the company is 'comfortable' hitting its vaccine delivery targets. But with its U.S. rollout underway, the pharma giant has run into some supply problems in Europe, Reuters reports. J&J’s shot isn’t yet authorized in Europe, but the company has been gearing up to supply a promised 55 million doses during the second quarter—and now it's hitting some snags, an official involved in supply talks told the news service. The shot is expected to win an EU authorization in the coming days, Reuters reports, and vaccinations in the bloc could start next month.The company notified European officials last week that it was “under stress” to meet the goal because of shortfalls in the supply of production materials, the source told Reuters. J&J might still be able to meet its target, the official added.

FiercePharma - March 9, 2021

View the full story here: https://www.fiercepharma.com/pharma/johnson-johnson-runs-into-vaccine-supply-issues-europe-threatening-second-quarter-delivery